Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Denis Naumov (Blagoveshchensk, Amur Oblast, Russian Federation), Denis Naumov, Juliy Perelman, Anna Prikhodko, Victor Kolosov, Elizaveta Sheludko. Role of TRPV1 and TRPV2 gene polymorphisms in the development of airway hyperresponsiveness to osmotic stimuli in patients with asthma. Eur Respir J 2016; 48: Suppl. 60, 1197

Member's Comments

No comment yet.

Related content which might interest you: Effect of TRPV4 gene polymorphisms on osmotic airway hyperresponsiveness in patients with asthma Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 TRPM8 gene polymorphisms and their relation to cold airway hyperresponsiveness in patients with bronchial asthma Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Effect of ADRB2 gene polymorphism on treatment outcomes in asthmatics: Cold airway hyperresponsiveness and asthma control Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Influence of beta2-adrenergic receptor polymorphism on methacholine hyperresponsiveness in asthmatic patients Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Association of AQP5 gene polymorphisms with osmotic airway hyperresponsiveness in asthma Source: International Congress 2019 – Genes and environment Year: 2019 Lung function impairment in adult asthma increases the risk of systemic inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Association of thymic stromal lymphopoietin gene polymorphisms with atopic status, pulmonary function and airway hyperresponsiveness in a Japanese adult asthmatic population Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Association between airway inflammation, airway remodelling and physiological changes in asthma Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 The role of the frizzled-8 receptor in COPD with chronic mucus hypersecretion Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Expression of genes associated with neurogenic inflammation in pediatric asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013